Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.095 | 0.07 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.1 |